Oxford Immunotec Revenue and Competitors

Boston, MA USA

Location

$150.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oxford Immunotec's estimated annual revenue is currently $49.2M per year.(i)
  • Oxford Immunotec's estimated revenue per employee is $193,750
  • Oxford Immunotec's total funding is $150.8M.

Employee Data

  • Oxford Immunotec has 254 Employees.(i)
  • Oxford Immunotec grew their employee count by -30% last year.

Oxford Immunotec's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Head Regulatory AffairsReveal Email/Phone
4
VP Commercial-AmericasReveal Email/Phone
5
Head OperationsReveal Email/Phone
6
VP, Finance & Business OperationsReveal Email/Phone
7
SVP Operations and DeliveryReveal Email/Phone
8
Director - R&D, AutomationReveal Email/Phone
9
Marketing Director EU/ROWReveal Email/Phone
10
Director, Global Technical ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Oxford Immunotec?

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company was founded in 2002 based on world-leading research at the University of Oxford. The European headquarters are located in Abingdon, UK and the North American headquarters are located in Marlborough, MA USA.

keywords:N/A

$150.8M

Total Funding

254

Number of Employees

$49.2M

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxford Immunotec News

2022-04-13 - Anatomic Pathology Market to reach US$ 61.1 Mn by 2030 – Comprehensive Research Report by FMI

In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec...

2015-05-14 - $475M fund will help commercialize Oxford University’s spinout tech firms

The University of Oxford has produced some of Britain’s greatest minds, and to help in its quest to stay at the forefront of technological innovation, the institution’s commercial arm has set up a £300 million ($475 million) fund to develop and bring to market companies based on the university’s ...

2012-06-18 - Oxford Immunotec Raises $28M in Equity Financing

Oxford Immunotec, a Oxford, UK-based medical diagnostic company developing tests in the fields of infectious and immunological disease, has raised $28m in equity financing. The round was led by new investors Imperial Innovations and Invesco Perpetual, with participation from existing shareholde ...

2010-04-30 - Oxford Immunotec Closes Second Tranche of $26M Series D Financing

Oxford Immunotec Ltd., an Oxford, UK-based manufacturer and marketer of T cell-based diagnostic tests, closed the second tranche of a $26m Series D financing. The financing was led by NLV Partners, with additional participation from new investor Kaiser Permanente Ventures and existing investors ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.4M2542%N/A
#2
$62.4M2709%N/A
#3
$82M27610%N/A
#4
$30.8M280-1%N/A
#5
$103.7M290-1%N/A